Explore insights, news, and background stories from the Greater Zurich Area – one of Europe’s most advanced business and innovation hubs. This is where international companies, tech pioneers, and investors find the latest updates on artificial intelligence, robotics, biotech, fintech, and more. Whether you're looking for real-world expansion cases, startup success stories, or key developments in Switzerland’s business environment, our articles offer firsthand perspectives and strategic guidance.
Government reserves coronavirus drugs
Schlieren ZH – The Swiss government has signed a reservation contract for a Covid-19 drug developed by Molecular Partners. The University of Zurich spin-off intends to start clinical trials in the fall.
Universities of applied sciences helps start-ups
A strong ecosystem for start-ups has developed in the Greater Zurich Area. Universities of applied sciences, including the Zurich University of Applied Sciences (ZHAW) and Zurich University of the Arts (ZHdK), also represent key drivers behind the systematic promotion of start-ups in high-tech industries in particular.
Helsinn opens plant for cancer drugs
Lugano/Biasca TI - Helsinn Advanced Synthesis, the production-focused subsidiary of the pharmaceutical firm Helsinn, has put its largest cancer department to date into operation. This will be used for the development, analysis and manufacturing of clinical and commercial cancer drugs
BBC Bircher launches new protection system
Beringen SH - BBC Bircher Smart Access is launching a modular security solution for all types of gates and doors on the market. For this, the company is using a brand-new radio transmission system.
Bottled-Up Investments
Sevensense to collaborate with DB
Sevensense Robotics AG from the Greater Zurich Area is one of three start-ups to have been chosen to participate in Deutsche Bahn’s robotics program. Their task to help shape the future of train travel.
EU gives the green light to Cutiss study in children
Zurich - The life sciences company Cutiss can now test its product candidate denovoSkin on children. The Paediatric Committee of the European Medicines Agency has issued a positive safety assessment. Cutiss is working to develop personalized skin transplants.
GZA strengthens life sciences research
Davos – The Swiss Institute of Allergy and Asthma Research Davos is to establish a Center for Proteomics through a special professorship for life sciences. Graubünden’s government intends to offer up to 3.49 million Swiss francs by 2026.
Tecan & Thermo Fisher expand corona testing capacity
Männedorf ZH – Thermo Fisher’s coronavirus testing system is to leverage automation technology from the Tecan Group. This will enable laboratories to double or even triple their testing capacity.
Meet with an expansion expert
Our services are free of charge and include:
- Introduction to key contacts in industry, academia, and government
- Advice on regulatory framework, taxes, labor, market, and setting up a company
- Custom-made fact-finding visits, including office and co-working space